Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-14 3:49 pm Unchanged |
2020-12-31 | 13G | Sigyn Therapeutics, Inc. SIGY |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-01-14 3:46 pm Purchase |
2020-12-31 | 13G | ShiftPixy, Inc. PIXY |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 0 0.740% |
0 (New Position) |
Filing History |
| 2021-01-14 3:44 pm Sale |
2020-12-31 | 13G | CANCER GENETICS INC CGIX |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 85 0.002% |
-227,187 (-99.96%) |
Filing History |
| 2020-12-08 11:41 am Purchase |
2020-12-07 | 13G | Oblong, Inc. OBLG |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 964 7.600% |
964 (New Position) |
Filing History |
| 2020-11-20 11:11 am Purchase |
2020-11-12 | 13G | PURESNAX INTL INC PSNX |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 8,528,835 9.990% |
8,528,835 (New Position) |
Filing History |
| 2020-11-02 1:22 pm Purchase |
2020-10-30 | 13G | Evogene Ltd. EVGN |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 313,295 8.810% |
136,824 (+77.53%) |
Filing History |
| 2020-10-30 09:08 am Purchase |
2020-10-28 | 13G | CANCER GENETICS INC CGIX |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 227,272 5.870% |
227,272 (New Position) |
Filing History |
| 2020-10-22 1:18 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 53,333 5.290% |
53,333 (New Position) |
Filing History |
| 2020-10-13 06:23 am Purchase |
2020-10-06 | 13G | Benitec Biopharma Inc. BNTC |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 23,719 9.178% |
23,719 (New Position) |
Filing History |
| 2020-09-01 4:32 pm Purchase |
2020-09-01 | 13G | Evogene Ltd. EVGN |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 176,471 5.580% |
176,471 (New Position) |
Filing History |
| 2020-08-27 2:42 pm Purchase |
2020-08-24 | 13G | NanoVibronix, Inc. NAOV |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 46,500 9.970% |
46,500 (New Position) |
Filing History |
| 2020-05-28 4:05 pm Purchase |
2020-05-22 | 13G | Qualigen Therapeutics, Inc. QLGN |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 2,480 9.900% |
2,480 (New Position) |
Filing History |
| 2020-05-06 3:52 pm Purchase |
2020-05-06 | 13G | AMERI HLDGS INC AMRH |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 321,423 9.900% |
321,423 (New Position) |
Filing History |